Showing results (311-320 of 379) with videos related to

Sort By:
Pageof 38
Journal of Public Health (Oxford, England)|May 4, 2012
Interaction of personality traits with social deprivation in determining mental wellbeing and health behavioursChris J Packard, Jonathan Cavanagh, Jennifer S McLean, et al.
JCI Insight|November 10, 2020
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humansJan Borén, Martin Adiels, Elias Björnson, et al.
BMJ (Clinical Research Ed.)|October 29, 2009
Differences in atherosclerosis according to area level socioeconomic deprivation: cross sectional, population based studyKevin A Deans, Vladimir Bezlyak, Ian Ford, et al.
Clinical Chemistry|August 1, 1997
Point: status of lipid and lipoprotein standardizationJ R McNamara, E T Leary, F Ceriotti, et al.
Journal of Internal Medicine|August 19, 2021
Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humansJan Borén, Martin Adiels, Elias Björnson, et al.
Diabetes Care|November 13, 2008
Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly populationPaul Welsh, Heather M Murray, Brendan M Buckley, et al.
Neuroimage. Clinical|January 8, 2016
Corrigendum to "Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: Results from the psychological, social and biological determinants of ill health (pSoBid) study" [Neuroimage Clin. 2 (2013) 646-57]Rajeev Krishnadas, John McLean, G David Batty, et al.
International Journal of Epidemiology|December 14, 2011
The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomesIan Ford, Simon P Mooijaart, Suzanne Lloyd, et al.
Psychosomatic Medicine|August 27, 2013
Socioeconomic deprivation and cortical morphology: psychological, social, and biological determinants of ill health studyRajeev Krishnadas, John McLean, G David Batty, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 28, 2020
Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 DiabetesMarja-Riitta Taskinen, Elias Björnson, Juhani Kahri, et al.
Pageof 38